Skip to main content
. 2012 Aug 3;35(6):943–948. doi: 10.1007/s10545-012-9513-y

Table 3.

Plasma riboflavin, FAD, and FMN levels (nmol/L) in individual #54994 before and after riboflavin treatment compared to reported individuals (Pat 1-3) with SLC52A3 mutations (Bosch et al 2011)

Treatment #54994 Normal range Pat 1 Pat 2 Pat 3 Normal range
No After 4 w No No No
Riboflavin 7.4 132.7 1.4 <1 7.6 (3.9–49)
FMN 10.1 17.5 1.7 <1 <1 (2.8–11.0)
FAD 325.6 399.7 (229.1–375.5) 31 30 24.5 (46–114)

Bold values are outside normal range given in brackets. w, weeks